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distribution in case and control groups, respectively, from
HWE can have considerable consequences for conclusions
made in all studies. Alarmed through the raised objection
that we might have misinterpreted our data, we carefully
considered Gyo¨rffy et al’s arguments.
In our study, we focused on the genetic variability of
seven loci that are considered to be related to a risk for
psoriasis (Richter-Hintz et al, 2003). In the case of two loci,
GSTM and NQOR, Gyo¨rffy et al found deviations from
HWE and stated that our conclusions are not tenable. But
tests for HWE are not available that can be applied to
dominant-recessive markers with only two alleles, e.g.,
GST. The genotype distribution of the NQOR locus indeed
deviated significantly from HWE, but the risk of mistyping
genotypes can increase the probability of making type II
errors (i.e., erroneously accepting deviations from HWE).
Assuming that only two rare NQOR homozygotes are not
classified correctly and using the Bonferroni correction for
multiple testing, no significant deviation from HWE was
found (p¼0.028). Therefore, we conclude that Gyo¨rffy
et al’s criticism based on their meta-analysis has no solid
basis for all of the reported cases.
Nevertheless, we agree with Gyo¨rffy et al’s statement
that genotypic data of case–control studies must first be
tested for deviations from HWE and results should be re-
ported. Deviations from HWE can point to either a sampling
bias, mistyping of genotypes, or spurious gene associations
because of population stratification. If genotype frequencies
of both groups do not deviate significantly from HWE, there
are no serious concerns about the genetic structure of
samples. If only the genotype distribution of the patient
group shows deviation from HWE, this may provide addi-
tional support for an association of the marker locus with
the disease in question. If, however, the genotype frequen-
cies found in the control group deviate from HWE, data
must be reanalyzed carefully for all the reasons mentioned
above.
Finally, although it would be best to analyze first the
control group genetic testing in clinical research has to fit
into practical possibilities. Nevertheless, we want to stress
that a case–control design can be an optimal choice for
many human genetic studies when appropriate statistics
and population genetic concepts are applied (Schulze and
McMahon, 2002).
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A Novel Deletion Mutation in Keratin 5 Causing the Removal
of 5 Amino Acids and Elevated Mutant mRNA Levels in
Dowling–Meara Epidermolysis Bullosa Simplex
To the Editor:
Epidermolysis bullosa simplex (EBS) is one of the three
broad groups into which cases of Epidermolysis bullosa are
classified on the basis of clinical, histological, and genetic
evidence obtained from the affected patient (Pulkkinen et al,
1999). EBS is further classified into three subgroups, EBS
Weber–Cockayne (EBS-WC), EBS Koebner (EBS-K), and
EBS Dowling–Meara (EBS-DM), on the basis of the severity
and distribution of the symptoms, the age of onset, and the
ultrastructural investigation of the epidermis and basement
membrane zone.
The phenotypic manifestations of the different subtypes
of EBS have been extensively reviewed elsewhere, as has
the experimental evidence initially linking keratins 5 (KRT5)
and 14 (KRT14) mutations to EBS (Fine et al, 1991; Ishida-
Yamamato, 1991; Vassar, 1991; Fine et al, 2000). The char-
acteristic bullae or blisters seen in EBS result from the lysis
of unusually fragile basal keratinocytes as a result of mu-
tations in the genes encoding KRT5 and KRT14. EBS-DM is
considered the most severe form of EBS with widespread
herpetiform blistering, frequent extracutaneous involve-
ment, and evidence of tonofilament clumping at the elec-
tron microscope level in basal keratinocytes (Irvine et al,
1999; Fine et al, 2000).
Here we report the identification of a novel mutation in
the 2B helical region of KRT5 in a three-generation non-
consanguinous Australian family of caucasian extraction
(Fig 1). The proband was the only member of the family to
Abbreviations: EBS, epidermolysis bullosa simplex; GAPDH,
glycerylaldehyde-3-phosphate; KRT5, keratin 5; KRT14, keratin
14; qPCR, quantitative polymerase chain reaction
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exhibit clinical symptoms of EBS, presenting at birth with
herpetiform blistering involving the limbs, trunk, and face.
Primers and PCR conditions used for the ampification of
KRT5 exons from genomic DNA extracted from peripheral
blood leucocytes were as reported previously (Stephens
et al, 1997). The study was approved by the institutional
ethics committee of the Southeast Sydney Area Health
Service and conducted according to the Declaration of
Helsinki principles. All patients and family members signed
informed consents.
Two 3 mm punch biopsies were taken from the underarm
skin of the proband in locations previously shown to be
affected by blistering and immediately immersed in RNA-
later transport solution (Qiagen, Hilden, Germany). Total
cellular RNA was used as a template for cDNA production,
from which the expression of the mutation was confirmed
and quantified using quantitative polymerase chain reaction
(qPCR).
The novel mutation detected in exon 7 of KRT5 in this
pedigree resulted in the deletion of five amino acid residues
from the 2B domain of K5, 6 residues downstream of the 2B
discontinuity (KRT5 429delRNKLA, K5 2B:69-73 del) (Fig 2).
The phenotypic expression of EBS-DM in this case has
shown significant amelioration in both severity and distri-
bution with age (Fig 1). No other mutations were found in
KRT14 or the remaining KRT5 exons.
The analysis (by direct sequencing) of both the pheno-
typically normal parents excluded the mutation in the other
family members. Analysis by gel electrophoresis separating
the smaller allele containing the deletion from the wild-type
allele excluded the mutation in 50 unaffected, unrelated
controls, showing that this mutation is found only in the
affected proband. Using the 15 nucleotide difference be-
tween the wild-type and mutant alleles, differential primers
were designed to selectively amplify either wild-type or
mutant alleles. Utilizing qPCR, RNA samples derived from
3 mm skin punch biopsies showed that, normalized against
the housekeeping gene GAPDH, the mutant transcript was
present at a level 2.7-fold greater than that of the wild-type
allele. qPCR calculations were performed using the DDCT
method as previously described, and melting curve analysis
was used to ensure the amplification of a single PCR prod-
uct (Livak et al, 2001).
The 2B region of the KRT5 protein is one of the four a
helical segments that comprises the rod domain. Each of
these four segments possesses a repeating heptad amino
acid residue motif (a–b–c–d–e–f–g)n, where a and d are gen-
erally predicted to be positions occupied by apolar residues
(North et al, 1994). The 2B region is thought to be highly im-
portant in facilitating the lateral alignment of keratin molecules
as a prelude to the formation of the KRT5/KRT14 obligate
heterodimers, which form the basis of the basal keratinocyte
intermediate filaments. The 2B segment differs from the re-
maining three in that the heptad repeat breaks down and
stutters in the middle of the segment (North et al, 1994).
The phenotype of the proband expressing clinically di-
agnosable EBS-DM in this study has exhibited significant
amelioration of severity with age. (Fig 1). Normal daily ac-
tivities are now generally unimpeded by blister formation,
which is now characterized by the less frequent occurrence
of grouped blisters.
In other forms of EBS, three previous non-missense ker-
atin mutations have been reported to lead to a range of
phenotypes:
(1) a mutation in the 30 splice acceptor site of KRT14 exon 1
leading to the development of a highly truncated keratin
protein within the 1B helical domain and severe reces-
sive EBS,
(2) a donor splice site mutation in KRT5 resulting in the
removal of 22 amino acids from the H1 and 1A rod do-
mains and the expression of EBS-DM,
(3) a 3 nucleotide deletion in the 2B domain of KRT14,
resulting in the development of EBS-WC (refer to
www.interfil.org for a comprehensive summary of EBS
mutations).
This is a report of a non-missense mutation in the 2B
domain of KRT5, which leads to the development of EBS-
DM. Interestingly, the deletion of a relatively large sequence
Figure 1
Clinical Features of mature affected proband. (A) Hyperkeratosis on
sole, (B) blister on upper arm, and (C) pedigree of affected family. Filled
symbol indicates proband.
Figure2
Schematic representation of novel DRNKLA identified in proband.
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of amino acid residues has, in this instance, led to the
development of a surprisingly mild phenotype. This is in
direct contrast to a number of cases in which a much
smaller genetic lesion has led to the development of per-
sistently severe EBS-DM (Cummins et al, 2001).
The alignment of six individual-type 2 keratins (KRT 1, 3,
4, 5, 7, 8) showed that the RNKLA motif is poorly conserved
across these 6 individual proteins, with only lysine (K) at
codon 431 being absolutely conserved. A review of the lit-
erature shows that no EBS-causing mutations have been
reported between codons 429 and 433 in KRT5. On the
basis of this information, it is possible that this region does
not play an important functional role, such that the mutation
seen in this family may not cause significant disruption
to normal intermediate filament assembly and function, at
least later in life.
Analysis of this region indicates that this region is able to
accommodate the helical interruption within a small region
of the protein (North et al, 1994). Even though the loss of five
amino acids from an exon is a significant genetic lesion, it is
possible in this case that the location of the lesion (in an
area of low sequence conservation that has been shown to
be able to accommodate other helical disruptions) and the
form of the mutation (the mutation is in-frame and does not
affect the downstream translation of the exon) contribute to
reducing the effect of the deletion and result in the expres-
sion of a mild disease phenotype.
The greater significance of the qPCR data in this case is
unknown; however, the finding that the mutant allele is
present (at the RNA level) in the cell at 2.7 times the level of
the normal allele disproved our initial hypothesis that the
disease phenotype was mild due to lack of mutant allele
expression. Further investigation into the effect of the ab-
normal mutant allele mRNA level identified may assist in
delineating the correlation between genotype and pheno-
type, which continues to increase in complexity as more novel
EBS mutations of this nature are identified and reported.
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Single Nucleotide Polymorphisms of the Fibroblast Growth Factor
Receptor 2 Gene in Patients with Chronic Venous Insufﬁciency
with Leg Ulcer
To the Editor:
Chronic, non-healing leg ulcers, frequently attributed to
chronic venous insufficiency result in an enormous de-
crease in the quality of patients’ life. Several factors are
suspected to play a role in the pathomechanism of pro-
longed wound healing in these patients, but the exact
pathogenesis of the disease is still unknown (Stucker et al,
2003). In this study, we aimed to identify single nucleotide
polymorphism (SNP) in the fibroblast growth factor
receptor-2 (FGFR-2) gene that might contribute to the
pathogenesis of prolonged wound healing in leg ulcer
patients.
Abbreviations: BEK, bacterially expressed kinase; CVI, chronic ve-
nous insufficiency; FGF, fibroblast growth factor; FGFR, fibroblast
growth factor receptor; KGFR, keratinocyte growth factor receptor;
SNP, single nucleotide polymorphism; UTR, untranslated region
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